Genome technologies and personalized dental medicine

Oral Diseases

Volumn 18, Issue 3, 2012, Pages 223-235

  Eng, G ^a   Chen, A ^a   Vess, T ^a,b   Ginsburg, G S ^a  

^a DUKE UNIVERSITY   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; DESFLURANE; DIHYDROCODEINE; ENFLURANE; HALOTHANE; HYDROCODONE; ISOFLURANE; KETAMINE; MORPHINE; OPIATE; OXYCODONE; SEVOFLURANE; TRAMADOL; WARFARIN;

ANALGESIA; ARTICLE; CANCER CELL; CHRONIC PAIN; CONFIDENTIALITY; DATA MINING; DENTAL CARIES; DENTAL PROCEDURE; DENTISTRY; DISEASE COURSE; DNA SEQUENCE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE INTERACTION; GENE TECHNOLOGY; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEAD AND NECK CANCER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MICROARRAY ANALYSIS; MOUTH CARCINOMA; MOUTH DISEASE; MOUTH HYGIENE; NOCICEPTION; OVERALL SURVIVAL; PERIODONTITIS; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEOMICS; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE;

COMPUTATIONAL BIOLOGY; DENTAL CARE; GENETIC TECHNIQUES; GENETIC TESTING; GENOME, HUMAN; HUMANS; INDIVIDUALIZED MEDICINE; MOUTH DISEASES; PERSONAL HEALTH SERVICES; TOOTH DISEASES;

EID: 84857796766     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01876.x     Document Type: Article

References (102)

1. Andia DC, de Oliveira NFP, Letra AM, Nociti Júnior FH, Line SR, de Souza AP (2010). IL8 gene promoter polymorphism (rs4073) may contributes to chronic periodontitis. J Periodontol. doi: 10.1902/jop.2010.100513.
2. Bahekar AA, Singh S, Saha S, Molnar J, Arora R (2007). The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 154: 830-837.
3. Beikler T, Peters U, Prior K, Eisenacher M, Flemmig TF (2008). Gene expression in periodontal tissues following treatment. BMC Med Genomics 1: 30.
4. Beltrán-Aguilar ED, Barker LK, Canto MT et al (2005). Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis - United States, 1988-1994 and 1999-2002. MMWR 54: 1-44.
5. Bretz WA, Corby PMA, Hart TC et al (2005). Dental caries and microbial acid production in twins. Caries Res 39: 168-172.
6. Burke W (2003). Genomics as a probe for disease biology. N Engl J Med 349: 969-974.
7. Campo-Trapero J, Cano-Sanchez J, Palacios-Sanchez B, Sanchez-Gutierrez JJ, Gonzalez-Moles MA, Bascones-Martinez A (2008). Update on molecular pathology in oral cancer and precancer. Anticancer Res 28: 1197-1205.
8. Clarke J, Wu HC, Jayasinghe L, Patel A, Reid S, Bayley H (2009). Continuous base identification for single-molecule nanopore DNA sequencing. Nat Nanotechnol 4: 265-270.
9. Corey LA, Nance WE, Hofstede P, Schenkein HA (1993). Self-reported periodontal disease in a Virginia twin population. J Periodontol 64: 1205-1208.
10. Covani U, Marconcini S, Giacomelli L, Sivozhelevov V, Barone A, Nicolini C (2008). Bioinformatic prediction of leader genes in human periodontitis. J Periodontol 79: 1974-1983.
11. Daly AK, Brockmoller J, Broly F et al (1996). Nomenclature for human CYP2D6 alleles. Pharmacogenetics 6: 193-201.
12. Ernst FD, Uhr K, Teumer A, Homuth G et al (2011). Replication of the association of chromosomal region 9p21.3 with generalized aggressive periodontitis (gAgP) using an independent case-control cohort. BMC Med Genet 11: 119.
13. Evans WE, Relling MV (1999). Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286: 487-491.
14. Fábián TK, Fejérdy P, Nguyen MT, Sati Cs, Csermely P (2007). Potential immunological functions of the salivary chaperone, Hsp70 in the mucosal and periodontal defense mechanisms (Review). Arch Immunol Ther Exp 55: 1-8.
15. Frueh FW, Gurwitz D (2004). From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community. Pharmacogenomics 5: 571-579.
16. Fujii M, Ishiguro R, Yamashita T, Tashiro M (2001). Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue. Cancer Lett 172: 187-192.
17. Fukuda K, Hayashida M, Ikeda K (2009). Postoperative pain management following orthognathic surgery in consideration of individual differences - is the antinociceptive effect of fentanyl related to the genotype involving nucleotide at OPRM1? Masui 58: 1102-1108.
18. Galloway J (2011). Putting the Teeth into the UK Biobank. Prim Dent Care 18: 6-12.
19. Genome Information Nondiscrimination Act (GINA). National Human Genome Research Instititue. Available at: [accessed on 18 April 2011].
20. Gettig E, Hart TC (2003). Genetics in dental practice: social and ethical issues surrounding genetic testing. J Dent Ed 67: 549-562.
21. Ghosh A, Ghosh S, Maiti GP et al (2008). Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: correlation with progression and prognosis. Int J Cancer 123: 2594-2604.
22. Giacomelli L, Covani U (2010). Bioinformatics and data mining studies in oral genomics and proteomics: new trends and challenges. Open Dent J 4: 67-71.
23. Giacomelli L, Marconcini S, Derchi G, Barone A, Covani U (2007). Leader genes: a data mining approach for molecular genomics. AMIA Annu Symp Proc 11: 963.
24. Ginsburg GS, Willard HF (2009). Genomic and personalized medicine: foundations and applications. Transl Res 154: 277-287.
25. Gunsolley J, Pandey J, Quinn S, Tew J, Schenkein H (1997). The effect of race, smoking and immunoglobulin allotypes on IgG subclass concentrations. J Periodont Res 32: 381-387.
26. Harismendy O, Notani D, Song X et al (2011). 9p21 DNA variants associated with coronary artery disease impair interferon-y signaling response. Nature 470: 264-268.
27. Hart TC, Ferrell RE (2002). Genetic testing considerations for oral medicine. Transfer of Advances in Sciences into Dental Education. J Dent Educ 66: 1185-1202.
28. Hart TC, Kornman K (1997). Genetic factors in the pathogenesis of periodontitis. Periodontol 2000 14: 202-215.
29. Helgadottir A et al (2007). A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316: 1491-1493.
30. Hettne KM, Weeber M, Laine ML et al (2007). Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: lipopolysaccharide as a case study. J Clin Periodontol 34: 1016-1024.
31. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002). A comprehensive review of genetic association studies. Genet Med 4: 45-61.
32. Hu S, Arellano M, Boontheun P (2008). Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14: 6246-6252.
33. Huang M, Spitz MR, Gu J. et al (2006). Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis 27: 2034-2037.
34. Humphrey SP, Williamson RT (2001). A review of saliva: normal composition, flow, and function. J Prosthet Dent 85: 162-169.
35. Jemal A, Siegel R, Ward E et al (2008). Cancer statistics. CA Cancer J Clin 58: 71-96.
36. Kaijser M (2003). Examples from Swedish biobank research. In: Hansson MG, Levin M, eds. Biobanks as Resources for Health. Uppsala University: Sweden, pp. 33-50.
37. Kalburgi NB, Bhatio A, Bilichodmath S, Patil SR, Mangalekar SB, Bhat K (2010). Interleukin-6 promoter polymorphism (-174G/C) in Indian patients with chronic periodontitis. J Oral Sci 52: 431-437.
38. Kang S, Yoon I, Lee H, Cho J (2011). Association between AMELX polymorphisms and dental caries in Koreans. Oral Dis 17: 399-406.
39. Katsanis SH, Javitt G, Hudson K (2008). Public health. A case study of personalized medicine. Science 320: 53-54.
40. Kent A (2003). Consent and confidentiality in genetics: whose information is it anyway? J Med Ethics 29: 16-18.
41. Kim H, Yi B, Kim I, Kwak Y (2011). Integrating clinical information in national biobank of Korea. J Med Syst 35: 647-656.
42. Kirchheiner J, Schmidt H, Tzvetkov M (2007). Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J 7: 257-265.
43. Kirkham J, Robinson C, Strafford SM et al (2000). The chemical composition of tooth enamel in junctional epidermolysis bullosa. Arch Oral Biol 45: 377-386.
44. Kuo WP (2003). Overview of bioinformatics and its application to oral genomics. Adv Dent Res 17: 89-94.
45. Kuo WP, Whipple ME, Sonis ST et al (2002). Gene expression profiling by DNA microarrays and its application to dental research. Oral Oncol 38: 650-656.
46. Leethanakul C, Patel V, Gillespie J et al (2000). Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19: 3220-3224.
47. de Leon J et al (2006). Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. Psychosomatics 47: 75-85.
48. Li Y, St. John MA, Zhou X et al (2004). Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10: 8442-8450.
49. Li Y, Elashoff D, Oh M et al (2006). Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 24: 1754-1760.
50. Li Y, Ge Y, Saxena D, Caufield PW (2007). Genetic profiling of the oral microbiota associated with severe early-childhood caries. J Clin Microbiol 45: 81-87.
51. Little J, Bradley L, Bray MS et al (2002). Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156: 300-310.
52. Marketwire (2008). ZS Genetics, Inc. to vie for ten million dollar archon X PRIZE for genomics. Marketwire. Available at: [accessed on 15 April 2011].
53. McPherson R, Kavaslar N, Stewart A, Roberts R et al (2007). A common allele on chromosome 9 associated with coronary heart disease. Science 316: 1488-1491.
54. 23andMe (2011). Oral and throat cancer sample report. Available at: [accessed on May 5 2011].
55. Michalowicz B, Diehl S, Gunsolley J et al (2000). vidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol 71: 1699-1707.
56. Miller C (2010). Study of factors of genetic susceptibility associated to severe caries phenotype (Cariogene). Available at: [accessed on 16 April 2011].
57. Milward MR, Chapple IL, Wright HJ, Millard JL, Matthews JB, Cooper PR (2007). Differential activation of NF-kappaB and gene expression in oral epithelial cells by periodontal pathogens. Clin Exp Immunol 148: 307-324.
58. Nakayama H, Ikebe T, Beppu M, Shirasuna K (2001). High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer 92: 3037-3044.
59. Nazmul-Hossain AN, Patel KJ, Rhodus NL, Moser KL (2008). Microarrays: applications in dental research. Oral Dis 14: 25-29.
60. Papadimitrakopoulou VA, Hong WK, Lee JS et al (1997). Low-dose isotretinoin versus β-carotene to prevent oral carcinogenesis: long-term follow-up. J Natl Cancer Inst 89: 257-258.
61. Papapanou PN, Abron A, Verbitsky M et al (2004). Gene expression signatures in chronic and aggressive periodontitis: a pilot study. Eur J Oral Sci 112: 216-223.
62. Patir A, Seymen F, Yildirim M et al (2008). Enamel formation genes are associated with high caries experience in Turkish children. Caries Res 42: 394-400.
63. Petersson GH, Isberg P, Twetman S (2010). Caries risk assessment in school children using a reduced Cariogram model without saliva tests. BMC Oral Health 10: 5.
64. Remmerbach TW, Wottawah F, Dietrich J, Lincoln B, Wittekind C, Guck J (2009). Oral cancer diagnosis by mechanical phenotyping. Cancer Res 69: 5.
65. Restrepo JG, Garcia-Martín E, Martínez C, Agúndez JA. (2009). Polymorphic drug metabolism in anaesthesia. Curr Drug Metab 10: 236-246.
66. Rich E, Burke W, Heaton C et al (2004). Reconsidering the family history in primary care. J Gen Intern Med 19: 273-280.
67. Sakamoto M, Huang Y, Ohnishi M, Umeda M, Ishikawa I, Benno Y (2004). Changes in oral microbial profiles after periodontal treatment as determined by molecular analysis of 16s rRNA genes. J Med Microbiol 53: 563-571.
68. Schaefer AS, Richter GM, Groessner-Schreiber B et al (2009). Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS Genet 5: e1000378.
69. Schlapbach R (2009). Next generation sequencing technologies. Molekular diagnostik. Functional Genomics Center: Zurich. Available at: [accessed on 16 April 2011].
70. Schwartz S, Doody D, Fitzgibbons E, Ricks S, Porter P, Chen C (2001). Oral squamous cell cancer risk in relation to alcohol consumption and alcohol dehydrogenase-3 genotypes. Cancer Epidemiol Biomarkers Prev 10: 1137-1144.
71. Searle R, Hopkins PM (2009). Pharmacogenomic variability and anaesthesia. Br J Anaesth 103: 14-25.
72. Shillitoe EJ, May M, Patel V et al (2000). enome-wide analysis of oral cancer - early results from the Cancer Genome Anatomy Project. Oral Oncol 36: 8-16.
73. Sidransky D (2002). Emerging molecular markers of cancer. Nat Rev Cancer 2: 210-219.
74. Silva SD, Cunha IW, Nishimoto IN et al (2010). Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas. Oral Oncol 45: e134-e139.
75. Slavkin HC. (1998). Toward increased sensitivity and specificity in the treatment of neoplastic disease. J Amer Dent Assoc 129: 473-478.
76. Slayton RL, Cooper ME, Marazita ML (2005). Tuftelin, mutans streptococci, and dental caries susceptibility. J Dent Res 84: 711-714.
77. Somogyi AA, Barratt DT, Coller JK. (2007). Pharmacogenetics of opioids. Clin Pharmacol Ther 81: 429-444.
78. Spielmann N, Wong DT (2011). Saliva: diagnostics and therapeutic perspectives. Oral Dis 17: 345-354.
79. Sreelekha T, Ramadas K, Pandey M, Thomas G, Nalinakumari K, Pillai M. (2001). Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 37: 593-598.
80. St John MA, Li Y, Zhou X. (2004). Interleukin 7 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130: 929-935.
81. Suzuki A et al (2004). Large-scale investigation of genomic markers for severe periodontitis. Odontology 92: 43-47.
82. Tanaka T (1995). Chemoprevention of oral carcinogenesis. Eur J Cancer B Oral Oncol 31: 13-15.
83. Tanaka T (1997a). Chemoprevention of human cancer: biology and therapy. Crit Rev Oncol Hematol 25: 139-174.
84. Tanaka T (1997b). Effect of diet on human carcinogenesis. Crit Rev Oncol Hematol 25: 73-95.
85. Tipton DA, Gay DC, DeCoster VA (2007). Effect of a cyclooxygenase-2 inhibitor on interleukin-1b-stimulated activation of the transcription factor nuclear factor-kappa B in human gingival fibroblasts. J Periodontol 78: 542-549.
86. Todd R, Wong DT (2002). DNA hybridization arrays for gene expression analysis of human oral cancer. J Dent Res 81: 89-97.
87. Tye CE, Pham CT, Simmer JP, Bartlett JD (2009). DPPI may activate KLK4 during enamel formation. J Dent Res 88: 323-327.
88. Vitorino R, Lobo MJ, Duarte JR, Ferrer-Correia AJ, Domingues PM, Amado FM. (2005). The role of salivary peptides in dental caries. Biomed Chromatogr 19: 214-222.
89. Voora D et al (2005). Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype. Thromb Haemost 93: 700-705.
90. Wang L (2009). Pharmacogenomics: a systems approach. Wiley Interdiscip Rev Syst Biol Med 2: 3-22.
91. Wendell S, Wang X, Brown M et al (2010). Taste genes associated with dental caries. J Dent Res 89: 1198-1202.
92. Werneck RI, Lázaro FP, Cobat A et al (2011). A major gene effect controls resistance to caries. J Dent Res 90: 735-739.
93. Winning T, Needleman I, Rohlin M et al (2008). Evidence-based care and the curriculum. Euro J Dent Ed 12: 48-63.
94. Wright JT (2006). The molecular etiologies and associated phenotypes of amelogenesis imperfecta. Am J Med Genet Part A 140A: 2547-2555.
95. Xie H, Frueh FW (2005). Pharmacogenomics step toward personalized medicine. Pers Med 2: 325-337.
96. National coalition of health professional education in genetics (NCHPEG) (2007). Available at: [accessed on 1 April 2011].
97. A catalog of published genome-wide association studies national human genome research institute online publication. Available at: [accessed on 18 April 2011].
98. Yue QY, Svensson JO, Alm C, Sjoqvist F, Sawe J. (1989). Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation. Br J Clin Pharmacol 28: 639-645.
99. Zambon J. (1996). Periodontal diseases: microbial factors. Ann Periodontol 1: 879-925.
100. Zarco MF, Vess TJ, Ginsburg GS (2011). The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis: doi: [Epub ahead of print].
101. Zhang L, Xiao H, Karlan S, Zhou H, Gross J et al (2010). Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS One 5: e15573.
102. Zheng Z, Park J, Guillemette C, Schantz S, Lazarus P (2001). Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 93: 1411-1418.